# Texas Health Presbyterian Hospital of Dallas Blood Bank – FDA Inspection, May 24, 2024

Source: https://www.keypedia.com/records/fda_inspections/texas-health-presbyterian-hospital-of-dallas-blood-bank/f5417669-5b20-4aaf-88fd-5fbd244bf295
Source feed: FDA_Inspections

> FDA inspection 1240230 of Texas Health Presbyterian Hospital of Dallas Blood Bank, May 24, 2024. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1240230
- Company Name: Texas Health Presbyterian Hospital of Dallas Blood Bank
- Inspection Date: 2024-05-24
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1067153 - 2018-09-12
- FDA Inspection 985514 - 2016-08-09
- FDA Inspection 871807 - 2014-03-27
- FDA Inspection 772306 - 2012-03-15
- FDA Inspection 649028 - 2010-02-09

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/ramon-l-gonzalez-prieto/f03487d2-7c8c-407f-8270-a838f7a7d127)

Company: https://www.keypedia.com/companies/texas-health-presbyterian-hospital-of-dallas-blood-bank/2fa5a3c7-9586-4ab2-a437-711e7af102dd

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d